This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharma Law USA
October 2025
Venue TBCBoston MA

Mark Ford
Partner at Wilmer Cutler Pickering Hale and Dorr LLP; Lecturer, Boston University School of Law
Speaker

Profile

Mark Ford is a lecturer at Boston University School of Law and an antitrust litigation partner at WilmerHale where he also serves as the Vice Chair of Regulatory and Government Affairs for firm’s Boston office. He represents clients in federal and state courts and in agency investigations in matters concerning alleged monopolization, restraints of trade, price fixing, bid rigging, price discrimination and other forms of anticompetitive and exclusionary conduct. Mr. Ford has substantial experience advising and representing clients in the pharmaceutical and biopharmaceutical industry. He has litigated matters and regularly counsels clients concerning brand-generic settlements as well as defending allegations of sham litigation, Walker Process fraud, alleged “patent thickets,” improper “Orange Book” listings, and “product hopping.” His clients are among the leading pharmaceutical and biopharmaceutical firms in the world, and he has represented those companies and their employees in federal and state courts, before the Federal Trade Commission, and in matters brought by the European Commission. In addition to his litigation practice, Mr. Ford regularly speaks and publishes on antitrust issues facing life sciences companies and teaches “Antitrust and Health Care” at Boston University School of Law, which focuses on pharmaceutical and biopharmaceutical antitrust law and policy. He is also Vice President of the Board of Directors for Greater Boston Legal Services.

Agenda Sessions

  • How are the Courts Approaching Product Hopping?

    3:30pm